|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.64 HKD | +2.66% |
|
+0.55% | -51.04% |
| Jun. 03 | ImmuneOnco Biopharmaceuticals Gets China's Phase 3 Trial Approval for Leukemia Drug | MT |
| May. 30 | ImmuneOnco Completes Filing with China Regulator for Conversion of H Shares | MT |
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. announced that the Group has successfully dosed the first patient for the Phase I clinical trial of IMM47 in Australia.
| 1st Jan change | Capi. | |
|---|---|---|
| -51.04% | 682M | |
| +16.73% | 121B | |
| +13.04% | 107B | |
| -5.80% | 24.82B | |
| +1.69% | 22.48B | |
| -10.09% | 18.32B | |
| -40.52% | 16.33B | |
| -14.00% | 15.31B | |
| +1.18% | 14.08B | |
| +24.18% | 11.74B |
IMMUNEONCO BIOPHARMACEUTICALS (SHANGHAI) INC. 
